申请人:Sasaki Kenji
公开号:US20120202980A1
公开(公告)日:2012-08-09
Provided is a novel antimicrobial agent. More specifically, provided is a novel antimicrobial agent capable of effectively acting on various resistant bacteria such as VSSA, MRSA, VISA, VRE, and VRSA. A novel flavanone derivative having a six-membered monosaccharide derivative, specifically, a glucose derivative or a galactose derivative is capable of effectively acting on the bacteria. More specifically, a compound represented by the general formula (I) is capable of effectively acting on the bacteria.
(In the formula: X represents a six-membered monosaccharide derivative; and Y is substituted by a hydroxyl group.)
提供了一种新型抗微生物剂。更具体地说,提供了一种能够有效作用于各种耐药细菌,如VSSA、MRSA、VISA、VRE和VRSA的新型抗微生物剂。一种新型的黄酮酮衍生物具有六元环单糖衍生物,具体而言,是葡萄糖衍生物或半乳糖衍生物,能够有效作用于细菌。更具体地说,由通式(I)表示的化合物能够有效作用于细菌。(在公式中:X代表六元环单糖衍生物;Y被羟基取代。)